- 2024,04,27
Hangzhou, December 23 (Xinhua) - In Wenzhou, Zhejiang, the birthplace of Chinese private enterprises, the experience of Yan Yiyi, the head of "Cheng Yi Pharmaceutical", can be considered legendary. This native descendant of a fisherman from Dongtou Island started from the "two big vats" and relied on courage and wisdom to create the "first pharmaceutical company in Wenzhou".
On April 12th, Wenzhou Mayor Yao Gaoyuan (middle) and his delegation came to Cheng Yi Pharmaceutical to investigate the development of the marine economy (provided by Cheng Yi Pharmaceutical)
From the original workshop style military family small factory to the current "main board listed company"; From Dongtou on the sea to the international metropolis of Shanghai, Cheng Yi Pharmaceutical, led by Yan Yiyi, has become a modern well-known pharmaceutical enterprise specializing in the production of capsules, injections, and raw materials for 53 years. Nowadays, the main products for arthritis, including glucosamine hydrochloride preparations and raw materials, occupy an important position in the domestic and international markets.
365 days a year, he is almost busy with company affairs every day, either on business trips, at the negotiation table, or busy working on an important matter for the company.
One third is in Shanghai, one third is in the Dongtou manufacturing department, and one third is in various parts of the country. After relocating the company's headquarters to Shanghai in 2018, Yan Yiyi was busier than before going public, with up to 13 customers a day. Although he is nearly seventy years old, his spirit is still hale and his thinking is agile. Standing in Shanghai, the leader of the Yangtze River Delta and the economic heart of the country, Yan Yiyi has rediscovered the feeling of "passion burning" back then. Starting again, he is strutting forward, preparing to lead the company towards the legendary path of "a century old enterprise, a billion dollar pharmaceutical enterprise".
Relying on the sea and eating the sea; Cheng Yi "specializes" in making good medicine
Yan Yiyi's entrepreneurial history can be understood as a microcosm of the "rise" of Chinese private enterprises.
Although compared to Western companies such as Novartis, Johnson&Johnson, and GlaxoSmithKline, the size of Zheng Cheng Yi Pharmaceutical Co., Ltd. is still very small. But in fact, Cheng Yi Pharmaceutical has become a major manufacturer of related pharmaceutical products and intermediates for multiple international multinational pharmaceutical companies mentioned above. For more than 50 years, Yan Yiyi's pharmaceutical factory has been suspended overseas, but Yan Yiyi's unwavering spirit has helped overcome difficulties and embarked on a path of development for pharmaceutical enterprises with island characteristics, Wenzhou characteristics, and Chinese characteristics.
From the workshop style military family small factory with "two big vats" to now becoming a leading enterprise in domestic marine medicine, Yan Yiyi only does one thing in her lifetime.
"Sincerely make medicine, focus on making medicine, and meticulously make medicine, "said Yan Yiyi, which is the secret to her own victory.
Relying on the sea and living towards the sea, island pharmaceutical enterprises have natural resource advantages in developing marine pharmaceuticals. "He smiled. In the past 40 years, although the Dongtou area where the enterprise is located has faced disadvantages such as inconvenient transportation, water and electricity shortages, and insufficient talent, the coastal areas of Dongtou are rich in shrimp and crab shell resources, and in recent years, Cheng Yi Pharmaceutical has developed into the largest manufacturer of glucosamine hydrochloride raw materials in China. Glucosamine hydrochloride is prepared by hydrolysis of chitin and is often extracted from shrimp and crab shells. Due to its light weight and large volume, it is not convenient for transportation and is usually produced in coastal areas.
In the process of accelerating development, deep cultivation of marine medicine has also become an important direction for Cheng Yi Pharmaceutical. "The articles of the sea are promising, and the company is constantly enriching the varieties of marine pharmaceuticals." Yan Yiyi said that at present, the company also has many products under research, mainly marine drugs, involving deep-sea fish oil, blood lipid, blood pressure, anti-tumor drugs, etc.
On November 8th, the Party Committee of Cheng Yi Pharmaceutical organized party members to visit the "Wenzhou Red Memory Theme Exhibition" (provided by Cheng Yi Pharmaceutical)
Crazy about medicine; Cracking global challenges
Xu is naturally sensitive to technology, and even after 39 years at the helm of Cheng Yi Pharmaceutical, Yan Yiyi's attention to quality improvement and technological updates has not stopped. Even today, he still maintains a hands-on and constantly improving management style. Impressively, in 2018, he led the innovative launch of the "Filling Plum Blossom Needle", which also solved global challenges in the pharmaceutical industry.
In the pharmaceutical industry, the phenomenon of residual liquid from the injection needle sticking to the neck wall of ampoules during the filling process and being carbonized at high temperature is known as "scorched head", which causes significant waste in the pharmaceutical production process.
In the past few years, the cumulative losses caused by "scorched head" by Cheng Yi Pharmaceutical have exceeded ten million yuan. And this is only the "tip of the iceberg" among more than 6000 pharmaceutical companies nationwide.
Faced with the challenge, Yan Yi was determined to overcome it. For several years, he frequently traveled between Zhejiang and Hubei. Later, he personally met with equipment design engineers from Chutian Technology and proposed a solution: after the equipment was filled, the nitrogen filling needle used a plum blossom needle to blow away the medicine liquid that was stuck on the glass wall, ultimately achieving the "miracle" of continuous production of 10% glucose solution for 2 days without a "scorched head". As a result, Yan Yiyi also became the first inventor of the patent.
The user is the most authentic and understands the situation the most. If it doesn't work during use, it just doesn't. We focus on the pharmaceutical industry and know how to make changes. "Recalling this later, Yan Yiyi was also a bit excited. He firmly believes that people move forward under pressure and have passion. Faced with pressure and challenges, don't avoid them, face difficulties head-on, and try to come up with some tricks to resolve them as much as possible. The resolution of the "scorched head" issue has also laid a solid foundation for the production of the Cheng Yi Pharmaceutical Preparation Building.
In 2017, Cheng Yi Pharmaceutical launched its initial public offering and raised 280 million yuan, of which 190 million yuan was used for the technical renovation project of the glucosamine hydrochloride preparation building. After the completion of the project, the company will have an annual production capacity of 90 million ampoule small volume injections, 210 million tablets, 950 million capsules and 120 million packets of granules. As the helmsman, Yan Yiyi also placed expectations on this. "In the era of aging population in China, there are many opportunities for the development of Cheng Yi Pharmaceutical. Especially our glucosamine hydrochloride is very effective in treating chronic arthritis in the elderly with minimal side effects
Three Centers Settled in Shanghai
If a thoughtful person carefully observes, on the economic map of Wenzhou, Cheng Yi Pharmaceutical, who has walked all the way from the "two big tanks" military small factory, has almost no companions or guides, and is simply a "lone ranger".
What is the secret to its victory? Focusing on the main business, pharmaceuticals. "Yan Yiyi's answer was very simple and clear.
In March 2017, Cheng Yi Pharmaceutical was listed on the Shanghai Stock Exchange, becoming the "first stock of Wenzhou Pharmaceutical"; In June 2018, Cheng Yi Pharmaceutical's headquarters moved from "sea" to Shanghai, achieving a leap in the platform and also leaving key pieces behind.
In Shanghai, the biggest feeling is the improvement of efficiency, attracting more pharmaceutical companies and talent elites to join. Not far from Shanghai Hongqiao Railway Station, Cheng Yi Pharmaceutical bought a first floor building of the Fuli Center, fully utilizing the advantages of the transportation core hub in the Yangtze River Delta region, "connecting everyone, talent, goods, and information, and reaching out to the world." Here, his "desperate San Lang" personality is perfectly presented.
The leap of the platform has brought Cheng Yi Pharmaceutical an "immediate" transcript.
In the first half of 2019, Cheng Yi Pharmaceutical achieved a double increase in revenue and net profit, achieving a revenue of 339 million yuan, a year-on-year increase of 34.77%; The net profit attributable to the parent company was 68.2722 million yuan, a year-on-year increase of 51.68%. Yan Yiyi said that in the future, Cheng Yi Pharmaceutical will continue to focus its product research and development on new products such as marine drugs, elderly medication, and anti-tumor drugs. It has established the first academician expert workstation in Dongtou, as well as the Cheng Yi Pharmaceutical Health Research Institute. At present, a batch of new products targeted by the company are being included in the development agenda.
I have fallen in love with pharmaceuticals in this lifetime and have never been tired of it. I have devoted my whole life to staying at the forefront of Cheng Yi Pharmaceutical and at the forefront of China's pharmaceutical industry. Looking back on my 39 year experience at the helm, Yan Yiyi was filled with emotion. He said that Wenzhou is a blessed place for private enterprises. As long as I persist in "focusing on professionalism, hard work, and continuous innovation," the dream of "a century old pharmaceutical enterprise, a billion dollar enterprise" is certain to have a promising future! From the sea to Shanghai, this leader seems to have seen the bright prospects of Cheng Yi Pharmaceutical.